The Journal of Experimental Medicine
Symposium on Dendritic Cells
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 15 November 2004. doi:10.1084/jem.20040511
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 10, 1243-1256
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, N. A.
Right arrow Articles by Borrow, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, N. A.
Right arrow Articles by Borrow, P.
Right arrowPubmed/NCBI databases
*Nucleotide*Protein
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response

Nicola A. Jones1, Xiping Wei3, Darren R. Flower2, MaiLee Wong1, Franziska Michor6,7,8, Michael S. Saag4,5, Beatrice H. Hahn4,5, Martin A. Nowak6,7,8, George M. Shaw3,4,5, and Persephone Borrow1

1 Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
2 Bioinformatics Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
3 Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, AL 35294
4 Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5 Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
6 Program in Theoretical Biology and Evolutionary Dynamics, Harvard University, Cambridge, MA 02138
7 Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
8 Department of Mathematics, Harvard University, Cambridge, MA 02138

Address correspondence to Persephone Borrow, Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, England, UK. Phone: 44-1635-577913; Fax: 44-1635-577901; email: persephone.borrow{at}jenner.ac.uk

CD8+ cytotoxic T lymphocytes (CTLs) play an important role in containment of virus replication in primary human immunodeficiency virus (HIV) infection. HIV's ability to mutate to escape from CTL pressure is increasingly recognized; but comprehensive studies of escape from the CD8 T cell response in primary HIV infection are currently lacking. Here, we have fully characterized the primary CTL response to autologous virus Env, Gag, and Tat proteins in three patients, and investigated the extent, kinetics, and mechanisms of viral escape from epitope-specific components of the response. In all three individuals, we observed variation beginning within weeks of infection at epitope-containing sites in the viral quasispecies, which conferred escape by mechanisms including altered peptide presentation/recognition and altered antigen processing. The number of epitope-containing regions exhibiting evidence of early CTL escape ranged from 1 out of 21 in a subject who controlled viral replication effectively to 5 out of 7 in a subject who did not. Evaluation of the extent and kinetics of HIV-1 escape from >40 different epitope-specific CD8 T cell responses enabled analysis of factors determining escape and suggested that escape is restricted by costs to intrinsic viral fitness and by broad, codominant distribution of CTL-mediated pressure on viral replication.

Key Words: cellular immunity • antigenic variation • HIV-1 • viremia • biological models


Abbreviations used in this paper: ß-gal, ß-galactosidase; DFOSx, days following onset of symptoms; NAb, neutralizing antibody; rVV, recombinant vaccinia virus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS